UK Clinical Research Delivery key performance indicators: methodology

AI Summary

The UK Clinical Research Delivery (UKCRD) programme methodology document provides a technical framework for understanding and interpreting key performance indicators (KPIs) within the United Kingdom's clinical research landscape. Published under the oversight of the Medicines and Healthcare products Regulatory Agency (MHRA) and collaborating bodies, this guidance explains the processes used to compile research statistics, the quality standards applied to the data, and the specific scope of information included in regular performance reports. While this specific document does not focus on individual company violations or specific inspection dates—as it is a structural methodology rather than an enforcement notice—it establishes the regulatory expectations for data reporting and performance tracking across the sector. The primary objective is to offer transparency to stakeholders regarding how clinical trial efficiency and delivery are measured at a national level. Required actions for clinical research sponsors and delivery organizations include utilizing these guidelines to interpret national statistics accurately and ensuring their own reporting practices align with the technical standards described. This guidance is subject to regular updates as the UKCRD programme evolves, ensuring that the measurement of research delivery remains accurate and supports the UK objective of providing a robust, efficient environment for clinical innovation and patient access to new treatments.